Top Markets
#1 ADO Protocol ADO Protocol +192.94%
#2 Islamic Coin Islamic Coin +155.28%
#3 GoPlus Security GoPlus Security +49.48%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +24.23%
#6 Verus Coin Verus Coin +13.55%
#7 o1.exchange o1.exchange +13.37%
#8 Casper Network Casper Network +12.96%
#9 SkyAI SkyAI +11.53%
#10 Pons Pons +10.30%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc.

CEMI
Rank in Stocks #33411
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in... Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.
Share Price
$0.455
Last synced: 2023-04-27
Market Cap
$7.70M
Change (1 day)
0.22%
Change (1 year)
0.00%
Country
US
Trade Chembio Diagnostics, Inc. (CEMI)

Category

Healthcare
Number of shares outstanding for Chembio Diagnostics, Inc. (CEMI)
Number of shares outstanding as of August 2026: 0
According to Chembio Diagnostics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Chembio Diagnostics, Inc. (CEMI) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 371.00M -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 705.30M -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 143.28M -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 80.10M -
US